Rachel H. Rose
-
- Monoclonal and Polyclonal Antibodies Research 8
- Pharmacology top 10%
-
- Biosimilars and Bioanalytical Methods 3
- Mast cells and histamine 2
-
- Receptor Mechanisms and Signaling 5
- Protein purification and stability 4
-
- Analytical Chemistry and Chromatography 2
-
- Neuroscience and Neuropharmacology Research 2
-
- Alzheimer's disease research and treatments 2
- Co-authors
- Manoranjenni ChettyIain GardnerBrian M. GurbaxaniMiroslav DostálekStephen J. BriddonMasoud JameiKatherine L. GillStephen J. Hill
- Journals
- CPT Pharmacometrics & Systems Pharmacology (2 papers)British Journal of Pharmacology (2 papers)Clinical Pharmacokinetics (2 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Rachel H. Rose
17 papers receiving 481 citations
Peers
Comparison fields: 5 of 81
- Radiology, Nuclear Medicine and Imaging 177
- Pharmacology 51
- Immunology 109
- Pharmaceutical Science 21
- Molecular Biology 231
Countries citing papers authored by Rachel H. Rose
This map shows the geographic impact of Rachel H. Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel H. Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel H. Rose more than expected).
Fields of papers citing papers by Rachel H. Rose
This network shows the impact of papers produced by Rachel H. Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel H. Rose. The network helps show where Rachel H. Rose may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rachel H. Rose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 12 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 1 | |
| 6 | 2020 | 15 | |
| 7 | 2019 | 1 | |
| 8 | 2019 | 1 | |
| 9 | 2017 | 22 | |
| 10 | 2016 | 66 | |
| 11 | 2015 | 27 | |
| 12 | 2014 | 43 | |
| 13 | 2014 | 27 | |
| 14 | 2013 | 184 | |
| 15 | 2012 | 45 | |
| 16 | 2009 | 36 | |
| 17 | 2009 | 1 |
About Rachel H. Rose
Rachel H. Rose is a scholar working on Radiology, Nuclear Medicine and Imaging, Internal Medicine, Immunology, Pharmacology and Analytical Chemistry, having authored 17 papers that have together received 492 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Receptor Mechanisms and Signaling (5 papers), Protein purification and stability (4 papers), Biosimilars and Bioanalytical Methods (3 papers), Mast cells and histamine (2 papers), Analytical Chemistry and Chromatography (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Alzheimer's disease research and treatments (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (177 citations), Pharmacology (51 citations), Immunology (109 citations), Pharmaceutical Science (21 citations) and Molecular Biology (231 citations). Rachel H. Rose has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Manoranjenni Chetty, Iain Gardner, Brian M. Gurbaxani, Miroslav Dostálek, Stephen J. Briddon, Masoud Jamei, Katherine L. Gill, Stephen J. Hill, Nicholas D. Holliday and Amin Rostami‐Hodjegan. Their work appears in journals such as CPT Pharmacometrics & Systems Pharmacology, British Journal of Pharmacology, Clinical Pharmacokinetics, Cancer Research and Alzheimer s & Dementia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.